Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Pellock

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
Neurology|July 1, 1991
A rational guide to routine blood monitoring in patients receiving antiepileptic drugsJ M Pellock, L J Willmore
Lancet (London, England)|October 7, 1995
Taming the brain storms: felbamate updatedM J Brodie, J M Pellock
Mental Retardation and Developmental Disabilities Research Reviews|December 7, 2000
Treatment of epilepsy in the multiply handicappedJ M Pellock, L D Morton
Acta Neurologica Scandinavica. Supplementum|November 9, 2011
Vigabatrin 35 years later - from mechanism of action to benefit-risk considerationsW D Shields, J M Pellock
Drugs|March 1, 1996
Diagnosis and treatment of epilepsy in children and adolescentsL D Morton, J M Pellock
Epilepsy Research|November 1, 1996
A decade of modern epilepsy therapy in institutionalized mentally retarded patientsJ M Pellock, P A Hunt
Pediatrics|December 1, 1995
Carnitine deficiencyP A Hunt, J M Pellock
Epilepsia|May 13, 1998
Felbamate: 1997 updateJ M Pellock, M J Brodie
Current Pharmaceutical Design|June 1, 2000
Overview of childhood epilepsy and epileptic syndromes and advances in therapyL D Morton, J M Pellock
Drug Safety|March 1, 1991
Risk-benefit assessment of carbamazepine in childrenM N Seetharam, J M Pellock
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Neurology|July 1, 1991
A rational guide to routine blood monitoring in patients receiving antiepileptic drugsJ M Pellock, L J Willmore
Lancet (London, England)|October 7, 1995
Taming the brain storms: felbamate updatedM J Brodie, J M Pellock
Mental Retardation and Developmental Disabilities Research Reviews|December 7, 2000
Treatment of epilepsy in the multiply handicappedJ M Pellock, L D Morton
Acta Neurologica Scandinavica. Supplementum|November 9, 2011
Vigabatrin 35 years later - from mechanism of action to benefit-risk considerationsW D Shields, J M Pellock
Drugs|March 1, 1996
Diagnosis and treatment of epilepsy in children and adolescentsL D Morton, J M Pellock
Epilepsy Research|November 1, 1996
A decade of modern epilepsy therapy in institutionalized mentally retarded patientsJ M Pellock, P A Hunt
Pediatrics|December 1, 1995
Carnitine deficiencyP A Hunt, J M Pellock
Epilepsia|May 13, 1998
Felbamate: 1997 updateJ M Pellock, M J Brodie
Current Pharmaceutical Design|June 1, 2000
Overview of childhood epilepsy and epileptic syndromes and advances in therapyL D Morton, J M Pellock
Drug Safety|March 1, 1991
Risk-benefit assessment of carbamazepine in childrenM N Seetharam, J M Pellock
Pageof 11